Raymed Labs - Cresanto Global Share Price

Cresanto Global Ltd. key Products/Revenue Segments include for the year ending 31-Mar-2024.

For the quarter ended 31-03-2026, the company has reported a Standalone Total Income of Rs .00 Crore, down 91.50 % from last quarter Total Income of Rs .02 Crore and down 99.67 % from last year same quarter Total Income of Rs .52 Crore. Company has reported net profit after tax of Rs -.24 Crore in latest quarter.

The company’s top management includes Mr.Prashant Nathmal Bajaj, Mr.Hitesh Bajoria, Mr.Nishant Nathmal Bajaj, Mrs.Urmila Hansraj Sharma, Mrs.Prity Bishwakarma, Mr.Vipul Subhashchandra Dubey, Mr.Pankesh Sutariya. Company has A Kay Mehra & Co. as its auditors. As on 31-03-2026, the company has a total of .43 Crore shares outstanding.

Raymed Labs Share Price Today is Rs. 4.65. On previous day, the Raymed Labs Share Price (NSE) closed at Rs. 4.02, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 32.27% of the stake in Raymed Labs shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Raymed Labs stocks was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. Out of the total DII holdings in Raymed Labs shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Raymed Labs stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Raymed Labs Dividend: Ever since 1992, Raymed Labs dividends has been paid out around 1 times. As on 20 Apr, 2026, 04:01 PM IST, The overall dividend yield for Raymed Labs stands at 0.0%. The last dividend paid was on September 16, 2002 (Rs. null). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. -1.01.

Raymed Labs Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 0.0 Cr. of sales and 91.5% of quarterly net loss, there have been multiple ups and downs in the Raymed Labs stock prices in the past few weeks. For example, Raymed Labs stock price on 18th of June 2026 was around Rs. 3.48. Raymed Labs share price now stands at an average of Rs. 4.65. Judging by last week's performance, stock is in up trend.

Raymed Labs has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Raymed Labs share.

Historical Prices and Performance:
Raymed Labs, incorporated in 1992 is a Small Cap company (with a market cap of Rs. 1.99) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Raymed Labs stock was 0.0%, 0.0%, 0.0%, 0.0% and 0.0% respectively.
The Raymed Labs share gave a 3 year return of 116.41% as compared to Nifty 50 which gave a return of 43.33%.
Raymed Labs announced 0.0% final dividend on September 16, 2002.

Key Metrics:
PE Ratio of Raymed Labs is -4.62
Prices/Sales Ratio of Raymed Labs is 35.16
Price/Book Ratio of Raymed Labs is -0.66

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at -4.62 and -0.66 respectively.

Leadership of Raymed Labs :
Pankesh Sutariya is Co. Secretary & Compl. Officer
Prashant Nathmal Bajaj is Managing Director & CFO
Nishant Nathmal Bajaj is Non Executive Director
Hitesh Bajoria is Non Executive Director
Urmila Hansraj Sharma is Non Executive Director
Prity Bishwakarma is Ind. Non-Executive Director
Vipul Subhashchandra Dubey is Ind. Non-Executive Director